GLP-1 agonists can affect mood: A case of worsened depression on Ozempic (semaglutide)
Conclusion In this small retrospective cohort of patients with ESRD, semaglutide use was associated with descriptive changes in glycemic parameters, body weight, and clinical outcomes over prolonged follow-up
While there are certainly some gaps present within this system (e.g., no formally established non-responder protocol, no previously published tapering pathway, etc.) the patient will need to take on the responsibility of seeking out information to ensure their needs are met
Liraglutide treatment achievers maintained an average loss of 8.4 Kg in their body weight compared to an average of 2.8 Kg in the placebo treatment group
Semaglutide carries certain contraindications and may not be suitable for everyone
PlexusDx requires a complete evaluation before prescribing to ensure the medication is appropriate for your individual situation